|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 36/45 | (2006.01) |
| A61K 9/4875 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 36/45 | (2013.01) | ||
| A61K 31/09 | (2013.01) | ||
| A61K 31/09 | (2006.01) | ||
| A61K 31/192 | (2013.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61K 31/216 | (2006.01) | ||
| A61K 31/216 | (2013.01) | ||
| A61K 31/34 | (2006.01) | ||
| A61K 31/34 | (2013.01) | ||
| A61K 31/341 | (2006.01) | ||
| A61K 31/341 | (2013.01) | ||
| A61K 31/352 | (2006.01) | ||
| A61K 31/352 | (2013.01) | ||
| A61K 31/353 | (2006.01) | ||
| A61K 31/353 | (2013.01) | ||
| A61K 31/7048 | (2006.01) | ||
| A61K 31/7048 | (2013.01) | ||
| A61P 13/00 | (2006.01) | ||
| A61P 13/00 | (2018.01) | ||
| A61P 13/02 | (2006.01) | ||
| A61P 13/02 | (2018.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/10 | (2006.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 15/10 | (2006.01) | ||
| A61P 15/10 | (2018.01) |
| (11) | Number of the document | 3782634 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20199906.7 |
| Date of filing the European patent application | 2014-11-11 | |
| (97) | Date of publication of the European application | 2021-02-24 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361902376 P | 2013-11-11 | US |
| (72) |
FROMENTIN, Emilie Annie Claudie , FR
KLAIBER, Douglas Andrew , US
SOUZA, Daniel David , US
|
| (73) |
Givaudan SA ,
Chemin de la Parfumerie 5, 1214 Vernier,
CH
|
| (54) | COMPOSITIONS FOR USES IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND OTHER DISEASES OR SYMPTOMS |
| COMPOSITIONS FOR USES IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND OTHER DISEASES OR SYMPTOMS |